KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Depreciation & Amortization (CF) (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $261000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 72.15% to $261000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 56.34% decrease, with the full-year FY2025 number at $2.3 million, down 56.34% from a year prior.
  • Depreciation & Amortization (CF) was $261000.0 for Q4 2025 at Biolife Solutions, down from $636000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.0 million in Q2 2023 to a low of $261000.0 in Q4 2025.
  • A 5-year average of $1.3 million and a median of $1.4 million in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): skyrocketed 180.21% in 2021, then tumbled 72.15% in 2025.
  • Biolife Solutions' Depreciation & Amortization (CF) stood at $1.6 million in 2021, then increased by 5.59% to $1.7 million in 2022, then dropped by 14.6% to $1.5 million in 2023, then tumbled by 36.17% to $937000.0 in 2024, then crashed by 72.15% to $261000.0 in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Depreciation & Amortization (CF) are $261000.0 (Q4 2025), $636000.0 (Q3 2025), and $674000.0 (Q2 2025).